Comments

Larimar Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Larimar Therapeutics (LRMR) operate in?

Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

LRMRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.87

-0.06-3.11%

At close: -

$1.87

0.000.00%

After Hours: May 23, 4:00 PM EDT

Larimar Therapeutics (LRMR) Forecast

News Earnings Larimar Therapeutics (LRMR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Larimar Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:LRMR | Benzinga

Explore Larimar Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LRMR.

Open	$1.91
Close	$1.87
Volume / Avg.	442.39K / 1.07M
Day Range	$1.86 - $1.93
52 Wk Range	1.61 - 11.20
Market Cap	$119.73M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	16.87%
Days to Cover	4.73

Recent News

This MicroStrategy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

What's Going On With Larimar Therapeutics Stock On Tuesday?

Larimar Therapeutics reports promising FXN level increases with 25 mg nomlabofusp, advancing towards dose escalation for Friedreich's Ataxia treatment.

Vandana Singh

Crude Oil Down 1%; Webuy Global Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.91
Close	$1.87
Volume / Avg.	442.39K / 1.07M
Day Range	$1.86 - $1.93
52 Wk Range	1.61 - 11.20
Market Cap	$119.73M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	16.87%
Days to Cover	4.73

About Larimar Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Larimar Therapeutics (LRMR) stock?

You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.

View our list of the best stock brokerages

Who are Larimar Therapeutics (LRMR) competitors?

Other companies in Larimar Therapeutics’s space includes: Atossa Therapeutics (NASDAQ:ATOS), Fate Therapeutics (NASDAQ:FATE), Sangamo Therapeutics (NASDAQ:SGMO), Agenus (NASDAQ:AGEN) and Kyverna Therapeutics (NASDAQ:KYTX).

What is the forecast, or price target, for Larimar Therapeutics (LRMR) stock?

Larimar Therapeutics has a consensus price target of $19.60.

What is the current price for Larimar Therapeutics (LRMR)?

The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $1.87 last updated May 23, 2025 at 4:00 PM EDT.

Does Larimar Therapeutics (LRMR) pay a dividend?

There are no upcoming dividends for Larimar Therapeutics.

When is Larimar Therapeutics (NASDAQ:LRMR) reporting earnings?

Larimar Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is Larimar Therapeutics (LRMR) going to split?

There is no upcoming split for Larimar Therapeutics.

What sector and industry does Larimar Therapeutics (LRMR) operate in?

Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.